Searchable abstracts of presentations at key conferences in endocrinology

ea0020p380 | Diabetes and Cardiovascular | ECE2009

Ca 19-9 levels in type 2 diabetes mellitus patients

Gul Kamile , Nas Sevinc , Sen Didem Ozdemir , Gumus Mehmet , Ersoy Reyhan , Cakir Bekir

Background: Ca 19-9 is a tumor-associated antigen. In this study, we aimed to compare Ca 19-9 levels in type 2 diabetes mellitus (DM) patients and healthy control group.Method: Two hundred and fifteen type 2 DM patients (82 male and 133 female) and 209 healthy control group (79 male, 130 female) age, sex and body mass index(BMI) matched were included in the study. Duration of diabetes, HbA1c and presence of complications were analyzed. Cases with high se...

ea0035p217 | Clinical case reports Pituitary/Adrenal | ECE2014

A huge metastatic adrenocortical carcinoma presenting with Cushing's syndrome and inferior vena cava thrombosis: case report

Kaya Mina Gulfem , Dellal Fatma Dilek , Ulas Arife , Gumus Mehmet , Kilicarslan Aydan , Yalcin Bulent , Ersoy Reyhan , Cakir Bekir

Background: Adrenocortical carcinoma (ACC) is a very rare but typically aggressive malignancy. About one to three quarters of ACC is functioning with excess hormonal production.Case: A 44-year-old female patient was admitted to out-patient clinic with obesity, oligomenorrhea and abdominal pain. She had central obesity, buffalo hump, and palpable flank mass. Hypertension, transient ischemic attack, and epilepsy history was present.S...

ea0016p767 | Thyroid | ECE2008

Case report: subcapsular hematoma complication during percutaneous laser ablation (PLA) to a hypoactive benign solitary thyroid nodule, and literature review of PLA- related complications

Cakir Bekir , Gul Kamile , Ersoy Reyhan , Topaloglu Oya , Agac Tuba , Aydin Cevdet , Dirikoc Ahmet , Gumus Mehmet , Korukluoglu Birol , Kusdemir Ahmet

Objective: Ultrasound (US) guided percutaneous laser ablation (PLA) is a new procedure utilized to decrease nodule volume in symptomatic thyroid nodules, to provide euthyroidism in autonomous hyperfunctioning thyroid nodules, and to decrease compressive symptoms palliatively in malignant nodules. Standard treatment protocol in symptomatic benign hypoactive thyroid nodules is surgery, if needed LT4 suppression, and radioiodine treatment in certain applications. We applied PLA t...

ea0032p487 | Diabetes | ECE2013

Insulin pump therapy as an obligatory treatment modality in a type 2 diabetic patient

Yilmaz Merve , Gedik Arzu , Demir Tevfik , Calan Mehmet , Gumus Tugba , Tunc Ulku Aybuke , Comlekci Abdurrahman , Yener Serkan , Eraslan Sevinc , Bayraktar Firat

Introduction: Continuous s.c. insulin infusion (CSII) therapy is a well documented treatment modality in type 1 diabetes mellitus (DM), but its usage in type 2 DM has not become prevalent so far. It may be a treatment alternative in severely insulin resistant type 2 diabetics recieving high doses of insulin. We present a type 2 diabetic patient that we had to shift from multiple dosage insulin (MDI) injection to CSII therapy due to the widespread echimosis at the insulin injec...

ea0016p763 | Thyroid | ECE2008

Case report: percutaneous laser ablation (PLA) to a functional euthyroid autonomous thyroid nodule, and histopathologic effects of PLA on nodule after thyroidectomy at 2nd year of procedure

Cakir Bekir , Gul Kamile , Ugras Serdar Nevzat , Ersoy Reyhan , Topaloglu Oya , Agac Tuba , Aydin Cevdet , Dirikoc Ahmet , Gumus Mehmet , Korukluoglu Birol , Kusdemir Ahmet

Objective: Percutaneous laser ablation (PLA) is a new procedure utilized to decrease nodule volume in symptomatic thyroid nodules, to provide euthyroidism in autonomous hyperfunctioning nodules, and to decrease compressive symptoms palliatively in malignant nodules. Standard treatment in autonomous thyroid nodules is radioiodine and surgery. In this report, we aimed to present this case to demonstrate changes in nodule histopathology, which was undergone thyroidectomy two year...